search
Back to results

Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation (VOICE-WEANING)

Primary Purpose

Ventilator Weaning, Weaning Failure, Brain Injuries

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Voice-Weaning
Sham control
Sponsored by
University of Erlangen-Nürnberg Medical School
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ventilator Weaning focused on measuring Critical Illness, Respiration Disorder, Neurology

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Intubation and controlled mechanical ventilation ≥48h due to a neurological disease
  • Weaning from mechanical ventilation intended by the attending physician
  • Obtained informed consent from the legal representative

Exclusion Criteria:

  • Age < 18 years
  • History of psychiatric disease
  • Weaning from mechanical ventilation not intended or decision to limit therapeutic interventions

Sites / Locations

  • University of Giessen

Arms of the Study

Arm 1

Arm 2

Arm Type

Sham Comparator

Experimental

Arm Label

Conventional arm

Voice-Weaning arm

Arm Description

Muted audio recordings of the patients relatives.

Audio recordings of the patients relatives including information on the patient's condition and recurrent request to breath in and out.

Outcomes

Primary Outcome Measures

Rate of weaning failure
Reintubation and/or resumption of ventilatory support following extubation or death following extubation or failed spontaneous breathing trial

Secondary Outcome Measures

Time of controlled ventilation
Rate of tracheotomy
Proportion of patients requiring tracheotomy performed as percutaneous dilatative tracheotomy or surgical tracheotomy
All cause mortality rate at 90 days
Rate of ICU delirium
Development of delirium according to the Confusion Assessment Method for intensive care unit (CAM-ICU)

Full Information

First Posted
December 31, 2018
Last Updated
January 31, 2023
Sponsor
University of Erlangen-Nürnberg Medical School
search

1. Study Identification

Unique Protocol Identification Number
NCT03795623
Brief Title
Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation
Acronym
VOICE-WEANING
Official Title
Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation in Patients With Severe Brain Injury - VOICE-WEANING, a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
January 31, 2021 (Actual)
Study Completion Date
April 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Erlangen-Nürnberg Medical School

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients with severe brain injuries, such as ischemic stroke and intracranial hemorrhage, frequently require mechanical ventilation. Weaning of stroke patients is complicated by impaired consciousness and respiratory drive. Higher rates of weaning failure and delayed extubation (≥ 48h) lead to ventilator associated pneumonia, higher mortality and necessity of tracheostomy. Therefore, improving the weaning of stroke patients from mechanical ventilation is warranted to prevent ventilator-associated complications and eventually improve clinical outcomes. This single-center, randomized, clinical trial aims at demonstrating that voices of patients' relatives support weaning from mechanical ventilation and reduce weaning failure in brain-injured patients.
Detailed Description
Methods: Adult ICU-patients with controlled mechanical ventilation ≥48h due to a neurological disease will be included in the intensive care unit. A predefined text - including information on the patient's condition and recurrent request to breath in and out - will be recorded as an audio file by one of the patient's relatives. Patients will be randomly assigned in a 1:1 ratio to the conventional treatment arm or the Voice-Weaning arm. In the conventional arm, audio recordings will be muted by an independent person resulting in a mute recording without audio signals. When conversion from controlled to assisted mechanical ventilation is intended according to standard treatment, audio recordings will be administered in repeat mode for 10 minutes and performed three times per day. If spontaneous breathing trials (SBT) are intended according to standard treatment, the audio recordings will be played during the SBT three times per day. Criteria for weaning not to be intended - according to Boles et al. (Weaning from mechanical ventilation. Eur Respir J. 2007) and adapted to neurological patients: Objective measurements: Unstable clinical condition Cardiovascular status (fC≥140/min, systolic BP <90mmHg or >180mmHg, more than minimal vasopressors) Metabolic status (e.g. inacceptable electrolytes) Inadequate oxygenation SaO2 ≤90% on FiO2 >40% or pO2/FiO2 <150mmHg or pO2/FiO2 <120mmHg in case of chronic hypoxemia (Horowitz index) PEEP>8cmH2O Inadequate pulmonary function fR ≥35/min MIP>(-20 -) -25cmH2O VT ≤5ml/kgKG VC ≤10ml/kgKG fR/VT ≥105 breaths/min x l (RSBI) significant respiratory acidosis (pH≤7.25) Unstable neurological condition sedation or inadequate mentation on sedation present or anticipated intracranial mass effect (e.g. midline shift >10mm or progression, basal cistern effacement or oculomotor disturbance, signs of transfalxial/transtentorial/transforaminal herniation elevation of intracranial pressure (>20 cmH2O) and/or obstructive hydrocephalus severe vasospasms (>6 kHz in transcranial Doppler, or determined by CT-A/CT-P) status epilepticus (determined by EEG) acute intracranial infection (without established and/or treated origin) Clinical assessment: Inadequate cough Excessive tracheobronchial secretion Disease acute phase for which the patient was intubated Ethics Approval: The Institutional Review Board of the Friedrich-Alexander-Universität Erlangen-Nürnberg approved of the study on 13 November 2018. Sample Size Calculation: The sample size is computed with 80% power and a 5% α-risk for the hypothesis of Voice Weaning achieving a 15% absolute weaning failure reduction. The sample size is increased by 10% to correct for dropouts and lost to follow up: a maximum of 354 patients will be included and an interim analysis be performed after inclusion of 50% of the calculated subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventilator Weaning, Weaning Failure, Brain Injuries
Keywords
Critical Illness, Respiration Disorder, Neurology

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Conventional arm
Arm Type
Sham Comparator
Arm Description
Muted audio recordings of the patients relatives.
Arm Title
Voice-Weaning arm
Arm Type
Experimental
Arm Description
Audio recordings of the patients relatives including information on the patient's condition and recurrent request to breath in and out.
Intervention Type
Other
Intervention Name(s)
Voice-Weaning
Intervention Description
Audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge.
Intervention Type
Other
Intervention Name(s)
Sham control
Intervention Description
Muted audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge.
Primary Outcome Measure Information:
Title
Rate of weaning failure
Description
Reintubation and/or resumption of ventilatory support following extubation or death following extubation or failed spontaneous breathing trial
Time Frame
first 28 days after start of ventilation, or until 48 hours after extubation, or discharge from intensive care, whichever came first
Secondary Outcome Measure Information:
Title
Time of controlled ventilation
Time Frame
first 28 days after start of ventilation or discharge from intensive care, whichever came first
Title
Rate of tracheotomy
Description
Proportion of patients requiring tracheotomy performed as percutaneous dilatative tracheotomy or surgical tracheotomy
Time Frame
first 28 days after start of ventilation or discharge from intensive care, whichever came first
Title
All cause mortality rate at 90 days
Time Frame
first 90 days after start of ventilation
Title
Rate of ICU delirium
Description
Development of delirium according to the Confusion Assessment Method for intensive care unit (CAM-ICU)
Time Frame
first 28 days after start of ventilation or discharge from intensive care, whichever came first

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Intubation and controlled mechanical ventilation ≥48h due to a neurological disease Weaning from mechanical ventilation intended by the attending physician Obtained informed consent from the legal representative Exclusion Criteria: Age < 18 years History of psychiatric disease Weaning from mechanical ventilation not intended or decision to limit therapeutic interventions
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hagen B. Huttner, MD, PhD
Organizational Affiliation
University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Joji B. Kuramatsu, MD
Organizational Affiliation
University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maximilian I. Sprügel, MD
Organizational Affiliation
University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Giessen
City
Gießen
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Because of local ethics committees restrictions the final decision upon release of the raw data has not been made.

Learn more about this trial

Voices of Patients' Relatives to Support Weaning From Mechanical Ventilation

We'll reach out to this number within 24 hrs